The study examined the impact of a standardized extract of Bacopa monnieri, rich in Bacoside A, on animal models designed to mimic aspects of Alzheimer’s disease, which is characterized by changes in cholinergic system functionality. The research focused on models induced by substances known to challenge memory and cognitive functions, mirroring some characteristics observed in Alzheimer’s disease, such as changes in acetylcholine levels and cholinergic receptor activity.
The administration of Bacopa monnieri over a 14-day period showed a notable influence in supporting memory functions, particularly highlighting its potential in moderating the memory challenges induced in these models. The findings suggest that the positive effects of Bacopa monnieri on memory may be linked to its interaction with the central cholinergic system, offering insights into its supportive role in cognitive health